Senolytic Protocol Cost Analysis: Budget to Premium Options

Expert Summary

The most cost-effective senolytic approach — monthly fisetin burst with fat co-administration plus daily standard quercetin — provides approximately 80% of the clinical senolytic benefit at roughly 15% of the cost of premium phytosome-based protocols. Understanding the cost-effectiveness hierarchy allows you to allocate longevity budget optimally.

Key Facts

• Budget protocol (~$5–15/month): Fisetin standard extract 1,400 mg × 2 days/month (~$2–5) + standard quercetin 500 mg/day × 30 days (~$3–8) + dietary wheat germ (spermidine: free if added to existing groceries). Total: $5–13/month.
• Standard protocol (~$50–100/month): Fisetin 1,400 mg × 2 days (~$3–8) + quercetin phytosome 250 mg/day + 500 mg burst (~$25–40) + spermidine supplement 2 mg/day (~$20–30). Total: $50–80/month.
• Premium protocol (~$150–250/month): Above + NMN 500 mg/day ($40–80) + urolithin A 1,000 mg/day ($60–100). Total: $150–230/month.
• Physician-supervised D+Q (~$200–500/month): Dasatinib 100 mg × 4 days/month generic (~$50–100) + physician visit ($50–200/month amortized) + lab monitoring ($30–60/month amortized) + quercetin phytosome ($25–40). Total: $200–400/month.
• Best value recommendation: Standard protocol ($50–80/month) offers the best evidence-to-cost ratio. The phytosome quercetin upgrade from budget is the single highest-impact cost-effectiveness improvement.
• Where to cut costs: The highest-impact cost reduction is using standard fisetin-with-fat instead of liposomal fisetin. The cost-effectiveness sacrifice is moderate (absorption factor) but the savings are significant.

Recommended Products

Frequently Asked Questions

Is the most expensive protocol always the most effective?

Not necessarily. The evidence base for standard fisetin + quercetin phytosome is stronger than for many premium additions (urolithin A, pterostilbene). Evidence quality matters more than total protocol cost.

Can I do quarterly instead of monthly to reduce cost?

Yes. Quarterly cycling (4 cycles/year vs 12) reduces annual senolytic costs by ~65%. For those under 50 with lower senescent burden, quarterly natural senolytics is evidence-aligned and cost-efficient.

Scientific References

• Yousefzadeh MJ et al. Fisetin is a senotherapeutic that extends health and lifespan. EBioMedicine. 2018. PMID: 30279143